Ciaran R. McFarlane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ciaran R. McFarlane has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Kung
Department of Life Sciences, Imperial College, London SW7 2AZ, United Kingdom
1 shared publication - Anna Schmidt
Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK
1 shared publication - Burak Veli Kabasakal
School of Biochemistry, University of Bristol, University Walk, Bristol BS8 1TD, U.K.
1 shared publication - Charles A. R. Cotton
Max Planck Institute for Molecular Plant Physiology
1 shared publication - James William Murray
Department of Life Sciences, Imperial College London
1 shared publication - Lucas Lieber
Department of Life Sciences, Imperial College, London SW7 2AZ, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 10 July 2024
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 80 (8) , 599-604
The crystal structure of Shethna protein II (FeSII) from Azotobacter vinelandii suggests a domain swap
The Azotobacter vinelandii FeSII protein forms an oxygen-resistant complex with the nitrogenase MoFe and Fe proteins. FeSII is an adrenodoxin-type ferredoxin that forms a dimer in solution. Previously, the crystal structure was solved [Schlesier et al. (2016), J. Am. Chem. Soc. 138, 239–247] with five copies in the asymmetric unit. One copy is a normal adrenodoxin domain that forms a dimer with its crystallographic symmetry mate. The other four copies are in an `open' conformation with a loop flipped out exposing the 2Fe–2S cluster. The open and closed conformations were interpreted as oxidized and reduced, respectively, and the large conformational change in the open configuration allowed binding to nitrogenase. Here, the structure of FeSII was independently solved in the same crystal form. The positioning of the atoms in the unit cell is similar to the earlier report. However, the interpretation of the structure is different. The `open' conformation is interpreted as the product of a crystallization-induced domain swap. The 2Fe–2S cluster is not exposed to solvent, but in the crystal its interacting helix is replaced by the same helix residues from a crystal symmetry mate. The domain swap is complicated, as it is unusual in being in the middle of the protein rather than at a terminus, and it creates arrangements of molecules that can be interpreted in multiple ways. It is also cautioned that crystal structures should be interpreted in terms of the contents of the entire crystal rather than of one asymmetric unit.
- 10 July 2024
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 80 (8) , 599-604
Open AccessThe crystal structure of Shethna protein II (FeSII) from Azotobacter vinelandii suggests a domain swap
The Azotobacter vinelandii FeSII protein forms an oxygen-resistant complex with the nitrogenase MoFe and Fe proteins. FeSII is an adrenodoxin-type ferredoxin that forms a dimer in solution. Previously, the crystal structure was solved [Schlesier et al. (2016), J. Am. Chem. Soc. 138, 239–247] with five copies in the asymmetric unit. One copy is a normal adrenodoxin domain that forms a dimer with its crystallographic symmetry mate. The other four copies are in an `open' conformation with a loop flipped out exposing the 2Fe–2S cluster. The open and closed conformations were interpreted as oxidized and reduced, respectively, and the large conformational change in the open configuration allowed binding to nitrogenase. Here, the structure of FeSII was independently solved in the same crystal form. The positioning of the atoms in the unit cell is similar to the earlier report. However, the interpretation of the structure is different. The `open' conformation is interpreted as the product of a crystallization-induced domain swap. The 2Fe–2S cluster is not exposed to solvent, but in the crystal its interacting helix is replaced by the same helix residues from a crystal symmetry mate. The domain swap is complicated, as it is unusual in being in the middle of the protein rather than at a terminus, and it creates arrangements of molecules that can be interpreted in multiple ways. It is also cautioned that crystal structures should be interpreted in terms of the contents of the entire crystal rather than of one asymmetric unit.